THEMIS MEDICARE
Themis Medicare Share Price
Themis Medicare Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in THEMIS MEDICARE
Start SIPThemis Medicare Investment Rating
-
Master Rating:
-
Themis Medicare has an operating revenue of Rs. 376.55 Cr. on a trailing 12-month basis. An annual revenue growth of 71% is outstanding, Pre-tax margin of 21% is great, ROE of 25% is exceptional. The company has a reasonable debt to equity of 8%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 17% and 11% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -11% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 81 which is a GOOD score indicating consistency in earnings, a RS Rating of 63 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 124 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 94 | 80 | 95 | 107 | 113 | 62 |
| Operating Expenses Qtr Cr | 74 | 65 | 78 | 84 | 72 | 49 |
| Operating Profit Qtr Cr | 20 | 14 | 17 | 23 | 40 | 13 |
| Depreciation Qtr Cr | 2 | 2 | 2 | 2 | 2 | 2 |
| Interest Qtr Cr | 2 | 2 | 2 | 2 | 3 | 3 |
| Tax Qtr Cr | 5 | 4 | 5 | 4 | 9 | 1 |
| Net Profit Qtr Cr | 12 | 8 | 12 | 15 | 27 | 7 |
Themis Medicare Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 0
- 20 Day
- 957.88
- 50 Day
- 891.71
- 100 Day
- 872.8
- 200 Day
- 900.86
- 20 Day
- 941.28
- 50 Day
- 863.49
- 100 Day
- 825.59
- 200 Day
- 900.05
Themis Medicare Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 1038.57 |
| Second Resistance | 1070.29 |
| Third Resistance | 1090.57 |
| RSI | 61.05 |
| MFI | 83.82 |
| MACD Single Line | 50.54 |
| MACD | 52.87 |
| Support | |
|---|---|
| First Resistance | 986.57 |
| Second Resistance | 966.29 |
| Third Resistance | 934.57 |
Themis Medicare Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 5,619 | 388,722 | 69.18 |
| Week | 18,004 | 940,910 | 52.26 |
| 1 Month | 20,346 | 930,016 | 45.71 |
| 6 Month | 6,025 | 354,080 | 58.77 |
Themis Medicare Result Highlights
Themis Medicare Synopsis
NSE-Medical-Generic Drugs
Themis Medicare Ltd. is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 394.61 Cr. and Equity Capital is Rs. 9.20 Cr. for the Year ended 31/03/2022. Themis Medicare Ltd. is a Public Limited Listed company incorporated on 31/05/1969 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24110GJ1969PLC001590 and registration number is 001590.| Market Cap | 924 |
| Sales | 377 |
| Shares in Float | 0.30 |
| No of funds | 1 |
| Yield | 0.5 |
| Book Value | 3.79 |
| U/D Vol ratio | 2.2 |
| LTDebt / Equity | 10 |
| Alpha | 0.04 |
| Beta | 0.8 |
Themis Medicare
| Owner Name | Jun-22 | Mar-22 | Dec-21 | Sep-21 |
|---|---|---|---|---|
| Promoters | 67.18% | 67.18% | 67.18% | |
| Foreign Portfolio Investors | ||||
| Financial Institutions/ Banks | 0.01% | 0.01% | 0.01% | |
| Individual Investors | 22.35% | 22.2% | 22.3% | |
| Others | 10.46% | 10.61% | 10.51% |
Themis Medicare Management
| Name | Designation |
|---|---|
| Mr. Hoshang Sinor | Chairman & Ind.Director |
| Dr. Dinesh S Patel | Executive Vice Chairman |
| Dr. Sachin D Patel | Managing Director & CEO |
| Mr. Rajneesh Anand | Non Executive Director |
| Mr. Lajos Kovacs | Non Executive Director |
| Dr. Gabor Gulacsi | Non Executive Director |
| Mr. Vijay G Agarwal | Independent Director |
| Mr. Hariharan Subramaniam | Independent Director |
| Ms. Manjul Sandhu | Independent Director |
| Mr. Bhaskar V Iyer | Independent Director |
| Mrs. Reena S Patel | Alternate Director |
Themis Medicare Forecast
Price Estimates
Themis Medicare Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2022-07-28 | Quarterly Results | |
| 2022-05-21 | Audited Results & Final Dividend | |
| 2022-02-11 | Quarterly Results | |
| 2021-11-12 | Quarterly Results | |
| 2021-08-13 | Quarterly Results |
Themis Medicare FAQs
What is Share Price of Themis Medicare ?
Themis Medicare share price is ₹1009 As on 30 September, 2022 | 02:41
What is the Market Cap of Themis Medicare ?
The Market Cap of Themis Medicare is ₹928.3 Cr As on 30 September, 2022 | 02:41
What is the P/E ratio of Themis Medicare ?
The P/E ratio of Themis Medicare is 15.7 As on 30 September, 2022 | 02:41
What is the PB ratio of Themis Medicare ?
The PB ratio of Themis Medicare is 3.2 As on 30 September, 2022 | 02:41